全文获取类型
收费全文 | 6051篇 |
免费 | 514篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 55篇 |
儿科学 | 237篇 |
妇产科学 | 127篇 |
基础医学 | 747篇 |
口腔科学 | 100篇 |
临床医学 | 735篇 |
内科学 | 1327篇 |
皮肤病学 | 51篇 |
神经病学 | 469篇 |
特种医学 | 189篇 |
外科学 | 1011篇 |
综合类 | 114篇 |
一般理论 | 2篇 |
预防医学 | 611篇 |
眼科学 | 120篇 |
药学 | 389篇 |
中国医学 | 15篇 |
肿瘤学 | 284篇 |
出版年
2023年 | 31篇 |
2022年 | 45篇 |
2021年 | 87篇 |
2020年 | 73篇 |
2019年 | 98篇 |
2018年 | 118篇 |
2017年 | 90篇 |
2016年 | 100篇 |
2015年 | 119篇 |
2014年 | 147篇 |
2013年 | 234篇 |
2012年 | 417篇 |
2011年 | 390篇 |
2010年 | 199篇 |
2009年 | 173篇 |
2008年 | 306篇 |
2007年 | 367篇 |
2006年 | 361篇 |
2005年 | 378篇 |
2004年 | 388篇 |
2003年 | 332篇 |
2002年 | 269篇 |
2001年 | 125篇 |
2000年 | 114篇 |
1999年 | 124篇 |
1998年 | 78篇 |
1997年 | 72篇 |
1996年 | 53篇 |
1995年 | 51篇 |
1994年 | 52篇 |
1993年 | 54篇 |
1992年 | 62篇 |
1991年 | 86篇 |
1990年 | 73篇 |
1989年 | 66篇 |
1988年 | 64篇 |
1987年 | 60篇 |
1986年 | 48篇 |
1985年 | 54篇 |
1984年 | 42篇 |
1983年 | 46篇 |
1982年 | 28篇 |
1981年 | 40篇 |
1980年 | 37篇 |
1979年 | 35篇 |
1978年 | 29篇 |
1976年 | 40篇 |
1975年 | 35篇 |
1973年 | 32篇 |
1972年 | 26篇 |
排序方式: 共有6583条查询结果,搜索用时 0 毫秒
21.
A multi-centre phase two study of intravesical epirubicin in the treatment of superficial bladder tumour 总被引:1,自引:0,他引:1
Epirubicin (4'-epi-adriamycin) was used in the treatment of widespread superficial carcinoma of the bladder. Thirty-seven patients received 50 mg in 50 ml of saline retained for 60 min. There was an overall response rate of 59% but this was of short duration. Thirty percent of patients progressed despite therapy. Therapy was associated with an incidence of side effects which necessitated therapy withdrawal in 12 (32.4%) patients. It is concluded that epirubicin, in the dose used in this study, cannot be recommended for routine intravesical chemotherapy and that further studies, at a reduced dosage, are necessary to evaluate this agent. 相似文献
22.
23.
24.
25.
Despite continued improvement in incidence of acute immune injury and short-term graft survival, late allograft dysfunction remains a significant problem in the renal transplant population. Recent reports suggest that rates of renal function decline are quite varied in the overall recipient population, and that individual rates for many recipients may not change substantially over time. Moreover, analyses also reveal distinct predictive factors for both early and late functional decline. Long-term outcome studies for renal transplantation, however, might be significantly limited by incomplete data sets for assessing clinical endpoints. In view of the heterogeneous factors that may cause progressive allograft injury, more routine biopsy sampling would allow a more complete characterization of induced injuries. Elucidating mechanisms of renal fibrosis in response to injury, in experimental systems and humans, is also an important goal in better understanding chronic allograft damage. Regulation of cell senescence genes and epithelial to mesenchymal transition, studied in other models of renal fibrosis, are likely relevant to studies of renal allograft dysfunction. Recent technical advances in analyzing biological samples may play a pivotal role in identifying and validating surrogate markers of allograft function for future interventional trials in transplantation. 相似文献
26.
27.
William T Mahle Robert N Vincent Alexandria M Berg Kirk R Kanter 《The Journal of heart and lung transplantation》2005,24(1):63-66
BACKGROUND: Hydroxymethylglutaryl CoA reductase inhibitors (statins) have been demonstrated to reduce the risk of developing coronary allograft vasculopathy (CAV) following heart transplantation in adults and are used routinely in many centers. CAV and lipid abnormalities have been reported to be less prevalent in pediatric heart transplant recipients. It is not known whether statins reduce the risk of CAV in this population METHODS: A retrospective review was performed to analyze the risk factors for developing CAV following pediatric heart transplantation with particular attention to the impact of pravastatin therapy. The study population was comprised of 129 pediatric patients who underwent 142 heart transplants at our institution from 1988 to 2003. The outcome variable was freedom from CAV, CAV being determined by coronary angiography or autopsy. RESULTS: CAV was identified in 25 recipients at a median of 3.7 years after transplantation. There were 331 patient-years of pravastatin therapy. Pravastatin therapy resulted in a reduction in total cholesterol levels, 162 +/- 29 to 137 +/- 20 mg/dl, p = 0.01. In multivariate analysis the use of pravastatin was associated with a lower incidence of CAV (p = 0.03), whereas an increased frequency of late rejection (p = 0.003) and earlier year of transplantation (p = 0.04) were associated with increased risk of CAV. CONCLUSIONS: The routine use of pravastatin was associated with a lower risk following pediatric heart transplantation. Further studies into the relationship between lipid abnormalities, inflammation and rejection, and the development of CAV in children are warranted. 相似文献
28.
A randomized controlled trial of electromagnetic therapy in the primary care management of venous leg ulceration 总被引:1,自引:1,他引:0
OBJECTIVE: The aim was to establish the potential efficacy, tolerabilityand side-effect profile of electromagnetic therapy as an adjunctto conventional dressings in the treatment of venous leg ulcers. METHOD: A prospective, randomized, double blind controlled clinicaltrial was carried out in a dedicated leg ulcer clinic basedin one urban general practice. Nineteen patients with leg ulcersof confirmed venous aetiology were assessed. The main outcomemeasures were rate and scale of venous leg ulcer healing, changesin patient-reported pain levels, quality of life, degree ofmobility, side effect profile and acceptability to patientsand staff. RESULTS: Sixty-eight per cent of patients attending this dedicated clinicachieved improvements in the size of their ulcer (4, 21%, healedfully) and in reduced pain levels (P < 0.05) during the trial,despite the chronicity of ulcer histories. Patients treatedwith electromagnetic therapy at 800 Hz were found at day 50to have significantly greater healing (P < 0.05) and paincontrol (P < 0.05) than placebo therapy or treatment with600 Hz. All patients reported improved mobility at the end ofthe study. The electromagnetic therapy was well tolerated bypatients, with no differences between groups in reporting adverseevents, and proved acceptable to staff. CONCLUSION: Despite the small numbers in this pilot study, electromagnetictherapy provided significant gains in the healing of venousleg ulcers and reduction in pain. Keywords. Electromagnetic therapy, RCT, leg ulcers, primary care. 相似文献
29.
30.
Chun Yuan Jay S. Tsuruda Kirk N. Beach Cecil E. Hayes Marina S. Ferguson Charles E. Alpers Thomas K. Foo D. Eugene Strandness 《Journal of magnetic resonance imaging : JMRI》1994,4(1):43-49
Atherosclerotic cardiovascular disease is the most common cause of death in the United States. Investigation of atherosclerotic plaque morphology and composition is important because the findings may be useful in predicting prognosis or response to therapy. This study presents high-resolution magnetic resonance (MR) imaging techniques developed on a 1.5-T whole-body imager with a custom-built surface coil, for characterizing the composition and morphology of plaque removed at carotid endarterectomy. The initial comparison of MR imaging and histologic results showed good correlation. In conjunction with MR angiography, these techniques could be used in in vivo imaging to define the size, location, and contents of atherosclerotic plaque at the carotid bifurcation. 相似文献